Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.

Coulson S, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L.

Complement Ther Med. 2013 Jun;21(3):172-9. doi: 10.1016/j.ctim.2013.01.007. Epub 2013 Feb 23.

PMID:
23642948
3.

Phytotherapy for benign prostatic hyperplasia.

Wilt TJ, Ishani A, Rutks I, MacDonald R.

Public Health Nutr. 2000 Dec;3(4A):459-72.

PMID:
11276294
4.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
5.

Pygeum africanum for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G.

Cochrane Database Syst Rev. 2002;(1):CD001044. Review.

PMID:
11869585
6.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

7.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.

8.

Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.

Porst H, Kim ED, Casabé AR, Mirone V, Secrest RJ, Xu L, Sundin DP, Viktrup L; LVHJ study team.

Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12.

PMID:
21871706
9.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R.

Cochrane Database Syst Rev. 2002;(3):CD001423. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423.

PMID:
12137626
10.

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E; European Silodosin Study Group.

Eur Urol. 2011 Mar;59(3):342-52. doi: 10.1016/j.eururo.2010.10.046. Epub 2010 Nov 10.

PMID:
21109344
11.

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

Lopatkin N, Sivkov A, Walther C, Schläfke S, Medvedev A, Avdeichuk J, Golubev G, Melnik K, Elenberger N, Engelmann U.

World J Urol. 2005 Jun;23(2):139-46. Epub 2005 Jun 1.

PMID:
15928959
12.

Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.

Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, Chadha-Boreham H.

Curr Med Res Opin. 1998;14(3):127-39.

PMID:
9787978
13.

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA.

BJU Int. 2003 Aug;92(3):267-70.

14.
15.

Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.

Mantovani F.

Minerva Urol Nefrol. 2010 Dec;62(4):335-40.

PMID:
20944533
16.

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.

Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M.

Clin Trials. 2009 Dec;6(6):628-36. doi: 10.1177/1740774509352199. Epub 2009 Dec 9.

17.

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).

Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM.

Prostate. 2014 Nov;74(15):1471-80. doi: 10.1002/pros.22866. Epub 2014 Aug 23.

PMID:
25154739
18.

A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia.

Marberger M, Chartier-Kastler E, Egerdie B, Lee KS, Grosse J, Bugarin D, Zhou J, Patel A, Haag-Molkenteller C.

Eur Urol. 2013 Mar;63(3):496-503. doi: 10.1016/j.eururo.2012.10.005. Epub 2012 Oct 12.

PMID:
23098762
19.

Botanical derivatives for the prostate.

Cristoni A, Di Pierro F, Bombardelli E.

Fitoterapia. 2000 Aug;71 Suppl 1:S21-8. Review.

PMID:
10930709
20.

Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study.

Vahlensieck W, Theurer C, Pfitzer E, Patz B, Banik N, Engelmann U.

Urol Int. 2015;94(3):286-95. doi: 10.1159/000362903. Epub 2014 Sep 5.

PMID:
25196580

Supplemental Content

Support Center